Business & FinanceHybrid
Director, Global Value & Access Strategy (Endocrinology))
Vertex PharmaceuticalsBoston, MA
$212,000–318,000/yr
Posted Oct 9, 2026
What you’d do
Leads global payer strategic planning to optimize value and access for atumelnant, a potential first-in-class therapy for Congenital Adrenal Hyperplasia. Full-time role based in Boston, MA. Found on the employer's careers page on Oct 17, 2026. Apply through the link.
You’ll need
- 8+ years biotech/pharma and/or payer experience
- Deep knowledge of US and ex-US healthcare systems
- Global payer strategic planning experience
- Specialty and/or rare disease access experience preferred
Our summary of the listing. The full listing has the details.